Showing results (311-320 of 319) with videos related to
Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaHervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.The Lancet. Oncology|July 30, 2016
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association studyZheng Li, Yi Xia, Li-Na Feng, et al.Nature Cell Biology|May 26, 2022
Pan-cancer pervasive upregulation of 3' UTR splicing drives tumourigenesisJia Jia Chan, Bin Zhang, Xiao Hong Chew, et al.Nature Methods|March 14, 2025
A systematic benchmark of Nanopore long-read RNA sequencing for transcript-level analysis in human cell linesYing Chen, Nadia M Davidson, Yuk Kei Wan, et al.Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic NeoplasmsJoseph D Khoury, Eric Solary, Oussama Abla, et al.American Journal of Hematology|June 21, 2022
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohortJing Quan Lim, Dachuan Huang, Jason Yongsheng Chan, et al.Nature Medicine|March 20, 2012
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancerKing Pan Ng, Axel M Hillmer, Charles T H Chuah, et al.The Lancet. Oncology|March 4, 2021
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working GroupPhilippe Moreau, Shaji K Kumar, Jesús San Miguel, et al.Leukemia|June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsRita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.Pageof 32